Strategic equity investment to accelerate growth and innovation in interventional spine care.

TAMPA, Fla., Aug. 27, 2025 — PainTEQ, a leader in minimally invasive solutions for sacroiliac (SI) joint dysfunction, today announced a majority growth recapitalization co-led by Signet Healthcare Partners and Windham Capital Partners, two U.S.-based healthcare investment firms with nearly 50 years of combined investment experience in medical technology companies. This recapitalization also includes a new equity investment by MVolution Partners.

With new ownership, this strategic investment will accelerate PainTEQ’s expansion by funding prospective clinical studies, advancing development of next-generation products, and expanding the company’s U.S. commercial presence.

PainTEQ’s flagship product, LinQ^®, is a proprietary, allograft-based, drill-less SI joint implant delivered via a minimally invasive posterior approach. To date, LinQ^® has been used in over 14,000 procedures and is supported by multiple peer-reviewed clinical studies, including the SECURE study, a prospective clinical trial demonstrating improvements in pain and function alongside a strong safety profile.

Under the leadership of CEO Shanth Thiyagalingam, PainTEQ has demonstrated strong operational discipline and commercial leadership. Thiyagalingam brings more than two decades of interventional experience, including senior commercial leadership roles at Abbott, Nevro, and Stryker.

“Partnering with experienced institutional healthcare investors at Signet and Windham marks an exciting chapter for PainTEQ,” said Thiyagalingam. “With a strengthened balance sheet and new committed ownership group, we are well positioned to deliver innovative solutions for patients suffering from SI joint dysfunction and to continue building a category-leading interventional platform. We are grateful to the founding team and prior owners for laying the groundwork that enables this next phase of company growth.”

Dr. Dawood Sayed, Professor and Division Chief of Pain Medicine at the University of Kansas Medical Center and Vice Chair and Co-Founder of the American Society of Pain and Neuroscience (ASPN), commented: “This investment validates SI joint fusion as a critical treatment pathway. It will accelerate innovation and advance research, expanding treatment options in interventional spine care and making this procedure a long-term standard of care.”

David Kereiakes, Managing Partner at Windham Capital Partners, commented: “We were compelled to invest in a future that delivers safer, more effective solutions for physicians and patients. PainTEQ’s innovative, minimally invasive technology and strong leadership are exactly what the interventional spine care market needs.”

Ashley Friedman, Managing Director at Signet Healthcare Partners, also added: “We are delighted to partner with Shanth and the PainTEQ team to leverage the company’s leadership position in SI joint treatment. With additional investment in clinical studies and pipeline products, we believe PainTEQ is well positioned to become a leading multi-product interventional spine platform.”

Raymond James served as financial advisor to PainTEQ. Legal counsel included Hill Ward Henderson; Bass, Berry & Sims; Sheppard, Mullin, Richter & Hampton; and Knobbe Martens. Transaction terms were not disclosed.

About PainTEQ
Founded in 2013 and based in Tampa, Florida, PainTEQ develops interventional pain management solutions focused on back pain and sacroiliac (SI) joint dysfunction. Its proprietary SI joint implant system has been used in more than 14,000 procedures to date, providing patients with minimally invasive options to help relieve chronic pain.

About Signet Healthcare Partners
Signet Healthcare Partners is a healthcare growth equity firm that invests in commercial-stage pharmaceutical (pharma services and therapeutics) and medical technology companies. Founded in 1998 and based in New York, Signet has invested in more than 60 companies, supporting entrepreneurs with capital, strategic guidance, and deep industry networks.

About Windham Capital Partners
Windham Capital Partners, founded in 2006, is a growth equity investment firm working at the intersection of medical technology and digital health. The firm invests in transformative companies and teams improving clinical outcomes, expanding access to quality care and creating greater efficiencies in healthcare. With deep expertise and a far-reaching network across medical devices, digital health, and life sciences, Windham partners with visionary founders and entrepreneurs to develop and elevate the standard of healthcare. 

SOURCE PainTEQ

The report finds that a majority of survey participants view venture debt as a flexible, founder friendly alternative to equity that supports growth without dilution rather than a last resort.

MENLO PARK, Calif., Aug. 26, 2025 — Runway Growth Capital LLC (“Runway”), a leading provider of growth loans to venture and non-venture-backed companies seeking an alternative to raising equity, today announced the release of the 2024-2025 Venture Debt Review, produced in partnership with PitchBook. The annual report provides a comprehensive look at the evolving venture debt landscape, pairing PitchBook’s proprietary market data with Runway’s original survey of founders, investors, and lenders—offering a view into how stakeholders are using debt in today’s market. 

The release of this year’s report comes against the backdrop of an increasingly concentrated venture debt market. PitchBook data previously released in early 2025 showed total venture debt deal value reached a record $53 billion in 2024—even as deal count dropped to the lowest level in a decade. This backdrop sets the stage for Runway’s deeper exploration of why debt is being used more selectively and strategically than ever. This reflects broader trends already visible across the ecosystem, including fewer, larger transactions as startups use debt more strategically to extend runway and preserve equity.

Runway’s proprietary survey findings offer fresh insight into how attitudes toward venture debt are shifting—highlighting changes in founder psychology, deal preferences, and broader market dynamics. Among the most notable data points:

• Late-stage lending is increasing
  • Nearly 60% of venture debt financings in 2024 occurred at the late or venture-growth stage.
  • 67% of respondents said they’re focused on funding expansion-stage companies, underscoring the increasing role of venture debt in supporting post product-market fit growth.
• Liquidity constraints are driving demand
  • While exit value rose to $152.9B in 2024, IPO timelines are the longest in over a decade, with 1,300+ companies still valued at $500M+.
• Perceptions and founder priorities are changing
  • 61% of respondents no longer view venture debt as “rescue financing.”
  • Founders are prioritizing flexibility and control over headline interest rates.
• Borrower behavior is evolving
  • In past years, interest rates were the top concern for founders; today, in a higher-rate environment, they prioritize flexibility, speed, and control in deal structures.
  • Lenders are responding by offering more borrower-friendly covenants and tailored repayment terms, suggesting a more sophisticated market dynamic.

“After years of capital abundance, startups are entering a new phase—one where how you raise money matters more than how much,” said David Spreng, Founder and CEO of Runway Growth Capital. “This report shows that venture debt has become a strategic lever for founders seeking flexibility and control in a more selective funding environment. We’re seeing a real departure from the old notion that debt is a sign of distress—this year’s data shows it’s increasingly a sign of discipline.”

The report also highlights prominent 2024 deals, such as Cohesity’s $3.1 billion debt financing following a $1B+ equity round, showcasing how venture debt can power ambitious growth plans without forcing founders to surrender equity.

The full report, including charts and commentary, is available for download at http://runwaygrowth.com/venture-debt-review

About Runway Growth Capital
Runway Growth Capital LLC is an investment adviser to investment funds, including Runway Growth Finance Corp. (Nasdaq: RWAY), a business development company, and other private funds, which are lenders of growth capital to companies seeking an alternative to raising equity. Led by industry veteran David Spreng, these funds provide senior term loans of a target of $30 million to $150 million to fast-growing companies based in the United States and Canada. For more information on Runway Growth Capital LLC and its platform, please visit www.runwaygrowth.com. 

About PitchBook
PitchBook is a financial data and software company that provides transparency into the capital markets to help professionals discover and execute opportunities with confidence and efficiency. PitchBook collects and analyzes detailed data on the entire venture capital, private equity, and M&A landscape—including public and private companies, investors, funds, investments, exits, and people. The company’s data and analysis are available through the PitchBook Platform, industry news, and in-depth reports. Founded in 2007, PitchBook operates globally with more than 3,000 team members. Its platform, data, and research serve over 100,000 professionals around the world. In 2016, Morningstar acquired PitchBook, which now operates as an independent subsidiary.

Forward-Looking Statements
Statements included herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition, or results and involve a number of risks and uncertainties. Actual results may differ materially from those in forward looking statements as a result of a number of factors, including those described from time to time in filings with the Securities and Exchange Commission made by Runway and Runway’s affiliated funds. Neither Runway nor Runway’s affiliated funds undertake a duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

SOURCE Runway Growth Capital LLC

MIAMI and AUCKLAND, New Zealand, Aug. 26, 2025 —  The round was led by Movac, one of New Zealand’s largest and longest-standing venture capital funds. It also drew strong participation from existing investors, including Bridgewest Ventures, which led Avasa’s seed round, and several new backers. The round was significantly oversubscribed and is expected to close at NZD$4.75 million.

Founded by clinician-bioengineer Dr. Nandoun Abeysekera, Avasa is transforming reconstructive microsurgery. Its category-defining device, the Avasa Coupler, addresses a critical unmet need by enabling safe, fast, and standardized reconnection of micro-arteries. This procedure has long required surgeons to hand-sew small arteries under a microscope, a complex and time-consuming process. 

“This is a huge milestone for Avasa,” commented Abeysekera, CEO and Founder. “After seven years of relentless R&D, we’ve reached design freeze for the Coupler and built our pre-production units, which have shown 100% success in chronic animal studies. In addition to my own experience as a plastics resident, 89% of the 100+ microsurgeons we interviewed expressed strong clinical demand for our solution. We’re laser-focused on getting it into their hands, and this capital will take us through FDA clearance and into the market in the next 18 months.”

The round’s lead investor, Movac, noted that Avasa was a clear fit for investment from its Emerge Fund. “With Nandoun having been a practicing surgeon, it was immediately obvious that he has intimate experience with the problems the Avasa Coupler addresses. He has built an impressive team, surrounded the business with world-class advisors, and the product they’ve developed is an elegant and IP-rich solution that addresses a clear pain point within a large but underserved market. We’re excited to be joining Avasa on their journey,” said Senior Investment Manager, Byron van Vugt.

Existing Investor, Bridgewest Ventures, first invested in Avasa in 2022. “We are immensely proud to have supported Nandoun and his team in reaching this pivotal milestone, with the Avasa Coupler poised to revolutionize the field. As Avasa takes its final steps toward FDA clearance and market entry, we’re energized by the opportunity to partner with Movac, whose leadership in this round has been invaluable,” said Saum Vahdat, CEO, Bridgewest Ventures.

Having secured the funding needed to progress through its FDA application, Avasa is now focused on completing the verification testing of its Coupler and is looking forward to its commercial launch. To help build its go-to-market strategy, Avasa recently recruited a senior commercial executive from Fisher & Paykel Healthcare. “Our technology is set to become the new standard for microvascular connections and will help make microsurgery safer, faster, and more accessible worldwide,” said Abeysekera.

About Avasa:

Avasa is a New Zealand-based medical device start-up developing solutions for reconstructive microsurgery. Founded in 2018, the company is nearing the launch of its first product, the Avasa Coupler, which standardizes and simplifies the process of Arterial reconnections.

About Movac: 

Movac is New Zealand’s most experienced and successful venture capital firm, with over 25 years of backing Kiwi entrepreneurs. As the country’s largest and longest-standing VC, Movac has raised $690m across eight funds, consistently delivering top-tier global returns. Movac’s portfolio includes many of New Zealand’s most exciting high-growth companies, such as Trade Me, Vend, Timely, Aroa Biosurgery, Tradify, Crimson Education, Auror and Dawn Aerospace. The firm is currently investing from Growth Fund 6, Emerge Fund 4, and the new Growth Opportunity Fund, supporting ambitious founders to scale globally and generate long-term impact for New Zealand.

About Bridgewest Group:

Bridgewest Group is an innovative and privately held global investment firm with over $3B in private capital. Founded in 1999, the global firm has earned a long-standing reputation for creating and scaling transformational businesses to achieve outsized success. Bridgewest Group leverages its expertise and global eco-community in key sectors where it can have the greatest impact including Life Sciences, Software, Semiconductor and Artificial Intelligence/Deep Tech. Customized financial investment services and diverse real estate holdings augment equity assets and support portfolio companies as they grow. Bridgewest Group is based in the US, with investments primarily in the US, Europe, China, Australasia and India.

Media Contact:

New Zealand – –  Dr. Nandoun Abeysekera, [email protected]

SOURCE Avasa

Elite Private Market Leaders to Convene September 15-17 at Hilton Los Angeles Universal City

LOS ANGELES, Aug. 26, 2025 — SuperReturn US West, the West Coast’s leading private capital conference, announced its preliminary line up for its upcoming event taking place September 15-17, 2025, at the Hilton Los Angeles Universal City. The event offers unparalleled networking opportunities and actionable insights from industry leaders on venture capital, private credit, artificial intelligence, fundraising strategies, LP allocations, and emerging investment trends. Wealth managers and financial advisors serving high-net-worth clients will benefit from specialized sessions on private wealth strategies. Additionally, service providers supporting the private equity and venture capital industries will gain valuable insights into market trends while connecting with potential clients.

“SuperReturn US West is establishing itself as the California connection point for private market leaders,” said Nedina Stephens, Event Director at Informa Connect. “This year’s expanded program features specialized summits, champagne roundtables, and exclusive LP-only sessions designed to deliver maximum value to attendees.”

What’s New for 2025

This year’s conference introduces several exciting enhancements:

• Three Specialized Summits on Monday, September 15: Private Wealth, Sport & Entertainment, and Private Credit – attendees can move freely between all three streams
• Champagne Roundtables covering critical topics including geopolitical impacts, direct investment strategies, and single family office oversight
• Invitation-Only Sessions including a single family office-only lunch and exclusive LP-only networking events

Distinguished Speaker Lineup

The 2025 program features 150+ expert speakers delivering data-rich presentations, panels, and interactive Q&As. Confirmed industry leaders include:

• Jonathan Sokoloff, Managing Partner, Leonard Green & Partners
• Caroline Greer, Managing Director, Commonfund OCIO
• Diana Carr-Coletta, Partner, Direct Lending, PGIM Private Capital
• Sud Murugesu, Partner, Head of West Coast, Partners Capital
• Jennifer Marques, Managing Director and Head of Strategy and Structuring, Oaktree Capital Management
• Nhora Otalora, Managing Director, HarbourVest Partners
• Ryan Smith, Managing Director, Secondary Investments, Hamilton Lane
• Orley J. Pacheco, Senior Financial Advisor, Sports and Entertainment Accredited Wealth Management Advisor, Wells Fargo Advisors
• Parth Patil, AI Engineer, Office of Reid Hoffman / Blitzscaling Ventures

Institutional Investors Already Confirmed

Leading institutional investors participating include Allstate Insurance, CalPERS, Cooper Family Office, LA Fire & Police Pensions, Motion Picture Industry Pension & Health Plans, QIC, San Antonio Fire & Police Pension Fund, LA City Attorney’s Office, and many more.

Benefits of Attending

SuperReturn US West offers attendees:

1. Premium Networking Opportunities – Connect with 300+ senior decision-makers in private markets
2. Insider Perspectives – Gain exclusive insights from elite LPs and GPs on critical market dynamics
3. Specialized Knowledge – Access expert insights on venture capital, private credit, and AI in 2025
4. Interactive Format – Participate in engaged conversations, invitation-only lunches, and champagne roundtables
5. Closed-Door Discussions – Benefit from candid conversations conducted under the Chatham House Rule

“SuperReturn US West is designed for development finance institutions, endowments, foundations, insurance companies, pension funds, single family offices, and sovereign wealth funds seeking to navigate today’s complex private capital landscape,” added Stephens. “The event provides a unique opportunity to learn from industry leaders while building valuable relationships in an intimate setting.”

Registration Information

SuperReturn US West 2025 offers complimentary attendance for qualifying LPs. Register by Friday August 29^th to save – BOOK NOW.

About SuperReturn US West
SuperReturn US West is the West Coast’s leading event in private markets, bringing together senior decision-makers from across the private capital ecosystem. The event features exclusive LP-only sessions, engaged conversations, invitation-only lunches, and champagne roundtables designed around the topics that matter most to participants. Wealth managers and financial advisors serving high-net-worth clients will benefit from specialized sessions on private wealth strategies. Additionally, service providers supporting the private equity and venture capital industries will gain valuable insights into market trends while connecting with potential clients.

SOURCE SuperReturn US West

Series B expansion will fuel growth of leading space solar tech with proven on-orbit performance

ALBUQUERQUE, N.M., Aug. 26, 2025 —  mPower Technology, Inc., the leader in flexible solar power for space, today announced a strategic investment from Lockheed Martin Ventures, the venture arm of Lockheed Martin Corporation. The investment is an add-on to mPower’s recent Series B funding round, bringing total Series B funding to over $24 million.

This capital will further accelerate mPower’s ability to scale production of its DragonSCALES™ solar modules. DragonSCALES provides an industry-leading flexible, resilient, and cost-effective solution for solar power in space, enabling new design possibilities for space missions.

“We are honored to welcome Lockheed Martin Ventures as a strategic investor,” said Kevin Hell, president and CEO of mPower Technology. “Lockheed Martin brings deep mission expertise and a bold vision for the future of space and national defense. Their support is a validation of our role in enabling rapid, scalable, and cost-effective solar power across the new space economy and in support of U.S. security priorities.”

Lockheed Martin Ventures joins an impressive group of investors in the Series B round, including Razor’s Edge Ventures and Shield Capital, both of which focus on technologies critical to national security and resilient space infrastructure.

“Space has never been more important to national security, and affordable, reliable power is a mission-critical enabler for future space operations,” said Chris Moran, vice president and general manager of Lockheed Martin Ventures. “The technology in development by mPower solves some of the hard challenges in unique and innovative ways—opening new doors for spacecraft design, power production, and scalability. We’re excited to support their continued growth and development as we advance U.S. leadership in space exploration.”

DragonSCALES has already been selected for several prominent space programs, including by Airbus Netherlands B.V. for their Sparkwing solar arrays which will power MDA’s AURORA satellites for low-earth orbit constellations like Telesat Lightspeed and the next-gen Apple-backed Globalstar constellation. Production is underway at mPower’s high-volume automated line located at Universal Instruments Corporation in Conklin, New York. The facility will produce over two megawatts of DragonSCALES annually, more than the combined global output of legacy gallium arsenide (GaAs) space solar suppliers.

With over 12 years of on-orbit heritage, mPower has become a trusted solar provider to companies including Airbus, Blue Origin/Honeybee, Firefly Aerospace, Lynk Global, and Gravitics.

About mPower Technology, Inc.

mPower Technology is reshaping the future of space solar with DragonSCALES™. Designed for mass production using standard silicon PV processes, DragonSCALES delivers high-performance, scalable solar power for spacecraft of all types. Learn more at mpowertech.com or follow us on LinkedIn, X, and Facebook.

About Lockheed Martin Ventures

Lockheed Martin is a global defense technology company driving innovation and advancing scientific discovery. Our all-domain mission solutions and 21st Century Security ® vision accelerate the delivery of transformative technologies to ensure those we serve always stay ahead of ready. More information at www.Lockheedmartin.com.

Media Contact:
Natalie Rizk
RiotMind
Phone: +1-505-252-4279
Email: [email protected]

SOURCE mPower Technology

The round was led by YZi Labs, Republic Digital, and HyperChain Capital, bringing Hemi’s total funding to $30 million as it prepares for its upcoming TGE.

CHICAGO, Aug. 26, 2025 — Hemi, the world’s largest programmability layer on Bitcoin, has closed a $15 million growth round, with participation from YZi Labs (formerly Binance Labs), Republic Digital, HyperChain Capital, Breyer Capital, Big Brain Holdings, Crypto.com, DNA Fund, Selini Capital, Protein Capital, Quantstamp, and Web3.com, amongst others. With over $1.2 billion in total value locked on the network, the funding will fuel further ecosystem growth on Bitcoin.

With Bitcoin‘s $2.3 trillion market cap, its potential in decentralized Finance (DeFi) remains largely untapped. Until now, developers had to choose between Bitcoin‘s unmatched security or the flexibility of DeFi on other chains. Hemi eliminates that trade-off, merging Bitcoin‘s trust and resilience with Ethereum programmability into a supernetwork, finally unlocking Bitcoin for use in modern financial applications.

Jeff Garzik, co-founder of Hemi and one of the earliest Bitcoin core developers, said: “Bitcoin doesn’t need to be reinvented; it just needs the right tools around it. Hemi provides DeFi protocols with a familiar way to build on Bitcoin, without requiring new skills, compromising on security, or sacrificing decentralization. Our partners share our conviction that Bitcoin can support more than just value transfer; it can support an entire ecosystem.” 

Hemi creates the platform for applications that allow users to earn, borrow, trade, and build on Bitcoin, while seamlessly connecting to other blockchains. The breakthrough Hemi Virtual Machine (hVM), a full Bitcoin node embedded inside an Ethereum Virtual Machine, creates a powerful new layer that fuses Bitcoin‘s security with Ethereum‘s flexibility, unlocking a new frontier for programmable bitcoin. 

The co-founders of Hemi are Jeff Garzik, a renowned former Bitcoin core developer; Maxwell Sanchez, the inventor of Proof-of-Proof (PoP) consensus protocol; and crypto pioneer and investor Matthew Roszak. Today, Hemi is trusted by over 100,000 verified users and supported by a vibrant community of more than 400,000 members. This momentum is driven by a network of over 70 ecosystem partners, including industry leaders such as Sushi, LayerZero, MetaMask, and Redstone, among others. 

Alex Odagiu, Investment Partner of YZi Labs, said, “For YZi Labs, belief in the team and belief in the product go hand in hand. Jeff, Maxwell, and Matthew have decades of experience, and the breakthroughs they’ve engineered with Hemi show they know how to turn that experience into working systems. Hemi creates a new foundation for Bitcoin-native applications that the whole industry has been waiting for.”

Joseph Naggar, CEO and CIO of Republic Digital, said, “Bitcoin‘s role as the world’s most secure settlement layer is unquestioned, but the lack of scalable programmability has limited its potential. Hemi directly addresses this by marrying Bitcoin‘s security with Ethereum‘s developer ecosystem through its supernetwork architecture. With the Hemi Virtual Machine, Proof-of-Proof consensus, and cross-chain ‘Tunnels,’ the platform enables new layers of Bitcoin DeFi, restaking, and asset programmability. We view this as critical infrastructure, and we are proud to back a team with the technical rigor and vision to deliver it.”

Stelian Balta, Founder of HyperChain Capital, added, “Hemi’s dedication to unifying Bitcoin and Ethereum through a smart tunnelling network is very commendable. Their technical proficiency and vision for scalable solutions make them a valuable addition to the blockchain community.”

In preparation for Hemi’s highly anticipated token generation event, with details soon to be finalized and announced, it has recently unveiled the tokenomics for $HEMI. 

About Hemi

Hemi makes Bitcoin programmable, yield-generating, and composable – unlocking the next wave of Bitcoin-based decentralized finance. Built on the combined strengths of Bitcoin and Ethereum, Hemi is a modular protocol engineered for performance, security, and programmability. Hemi was co-founded by Jeff Garzik, a former Bitcoin core developer; Maxwell Sanchez, inventor of the Proof-of-Proof consensus protocol; and crypto pioneer and investor Matthew Roszak. Hemi is backed by leading investors including YZi Labs (formerly Binance Labs), Breyer Capital, Big Brain Holdings, Republic Digital, Crypto.com, and HyperChain Capital. Follow Hemi on X and LinkedIn.

Photo – https://mma.prnewswire.com/media/2758067/Hemi_pre_TGE_growth_round.jpg

SOURCE Hemi

NEW YORK, Aug. 26, 2025 — Polymarket, the world’s largest prediction market, today announced that Donald Trump Jr. has joined Polymarket’s advisory board, and that 1789 Capital has made a strategic investment in the company. Terms of the investment were not disclosed.

1789 Capital is a pioneering investment firm dedicated to funding the next era of American exceptionalism. Mr. Trump Jr., a partner at 1789 Capital, brings decades of experience in forward-thinking business innovation and strategic perspective to Polymarket’s advisory board as the company looks to continue driving global adoption of prediction markets. The power of this investment, coupled with the additional expertise to Polymarket’s advisory board, further powers an effort to expand its footprint as the go-to platform for accurate, real-time insights into public sentiment on topics ranging from politics and economics to culture and global events.

“This strategic investment marks a significant milestone for Polymarket. Our long-term partnership with 1789 Capital will help reinforce Polymarket’s leading position as a trusted source of free, transparent and accurate market information in the U.S. and around the world,” said Shayne Coplan, Founder and CEO of Polymarket. “We are proud to formally welcome 1789 Capital as a strategic partner and Donald Trump Jr. to our advisory board as we continue building our platform to reflect real-world sentiment, in real time, for all to see.”

“Polymarket is the largest prediction market in the world, and the U.S. needs access to this important platform,” said Donald Trump Jr. “Polymarket cuts through media spin and so-called ‘expert’ opinion by letting people bet on what they actually believe will happen in the world. I am pleased that 1789 Capital is investing in Polymarket and am honored to join the company’s advisory board. I look forward to working with the team to advance its mission of bringing truth and transparency to everyone – including the U.S.”

“1789 Capital looks to invest in companies that are entrepreneurial, innovative, and demonstrate great potential for growth. Polymarket meets each of these criteria,” said Omeed Malik, Founder of 1789 Capital. “Polymarket stands at the intersection of free expression and financial innovation by empowering individuals with real-time truth in a world clouded by noise, and we are proud to support its vision.”

Most recently, Polymarket completed the $112 million acquisition of QCEX, a CFTC-licensed exchange and clearinghouse, paving the way for its re-entry into the U.S. market. The company also announced a partnership with 𝕏 as its Official Prediction Market Partner.

Since its launch in 2020, Polymarket has experienced tremendous growth as it has emerged as a vital source of trusted real-time information around the world. In the first half of 2025 alone, users have already made about $6 billion in predictions on the platform. To explore live markets and stay ahead of the curve, visit polymarket.com.

About Polymarket
Polymarket is the world’s largest prediction market. On Polymarket, traders predict the outcome of future events and win when they are right. As traders react to breaking news in real-time, market prices are the best gauge of the likelihood of events occurring. Institutions, individuals, and the media rely on these forecasts to report the news and better understand the future. Across politics, current events, pop culture, and more, billions of dollars of predictions have been made so far on Polymarket in 2025.

About 1789 Capital
Founded in 2022 by Omeed Malik and Chris Buskirk, 1789 Capital is an investment firm that focuses on providing financing to companies in the budding Entrepreneurship, Innovation & Growth (“EIG”) economy, which is driving the next era of American prosperity. The firm is based in Palm Beach, Florida.

Contact
[email protected] 

SOURCE Polymarket

New funding will accelerate Slant’s nationwide rollout, helping financial advisors double their capacity and serve hundreds more clients each year.

LEHI, Utah, Aug. 26, 2025 — Pageport, the company behind marketing and client engagement tools used by more than 1,000 financial advisors nationwide, today announced it has raised $3.3 million in funding from 2048 Ventures and Matchstick Ventures to launch Slant, its AI-first CRM designed exclusively for financial advisors, giving them the tools to serve more clients in less time..

Slant was built to help advisors serve more clients while strengthening the personal relationships that set them apart. For years, Pageport has heard the same frustration from hundreds of advisors: most incumbent CRMs do little beyond storing client data and tracking tasks. They don’t actively help advisors grow their practice or deepen relationships. Slant changes that – transforming the CRM into an active partner that prepares meetings, sends follow-ups, schedules reviews, and keeps client relationships moving forward.

“Financial advice changes lives—but too many Americans don’t have access to it,” said Michael Sheerin, [Title Placeholder]. “Slant’s approach empowers advisors to dramatically increase capacity while keeping their relationships personal and authentic. It’s technology that expands the human impact of financial advice.”

Built to increase advisor capacity

Most advisors can only serve 70–90 clients effectively, which means great advice is often reserved for the wealthiest households. Slant’s mission is to help advisors double their capacity, enabling them to work with hundreds more families and individuals—closing the advice gap that leaves millions without guidance.

AI agents that keep work moving

Slant’s AI Agents act as proactive teammates, handling the work that typically slows advisors down:

• Nudges – Timely, personalized prompts that not only tell you what needs to be done, but also do the heavy lifting for you. Whether it’s a client birthday, a follow-up after a meeting, or an RMD reminder, Slant drafts the email, queues the text, or schedules the outreach—so acting on it takes seconds, not hours.
• Meeting & Scheduling Agents – Slant handles every step of the meeting process for you. Beforehand, agents will prepare a personalized agenda, pull the right documents, and surface key client details. They’ll reach out to propose times, manage confirmations and reminders, and handle reschedules. After the meeting, agents will log notes, update the record, and queue follow-up—keeping the entire workflow moving without constant back-and-forth.
• Chat – An AI-powered assistant embedded in Slant, ready to answer questions, recall client details, find documents, and draft outreach—turning the CRM into an on-demand knowledge partner.

About Pageport

Pageport builds technology that helps financial advisors grow their practices and strengthen client relationships. Trusted by more than 1,000 advisors, Pageport’s solutions—including the newly launched Slant CRM—automate client engagement, meeting preparation, compliance workflows, and personalized outreach. Learn more at slant.app and see how Slant is redefining the CRM for financial advisors.

Media Contact

Hayden Neal

GTM Lead

[email protected]

(385) 342-3244

Slant.app

SOURCE Pageport

SAN DIEGO, Aug. 26, 2025 — Debut, the biotech beauty leader, has secured $20M in investment to accelerate the expansion of its proprietary, AI-based ingredient discovery platform to advance skin longevity innovation and scale its formulation business in the US and Asia.

The funding will propel the discovery of next-generation ingredients that target the 14 hallmarks of aging and empower Debut’s global beauty partners to innovate with peak-performing biotech ingredients and formulations married to novel claims. It will also enable beauty brands at all stages of growth to outsource their formulation innovation in record time, at scale and without the heavy upfront R&D expense associated with biotech.

“Debut is laser-focused on staying at the forefront of skincare innovation and bringing cutting-edge biotech to every beauty brand with the highest-performing and most differentiated ingredients. This funding will enhance our ability to screen upward of 50 billion ingredients to explore the 99.999 percent of unknown molecules that can optimize skin health and make skin longevity a reality,” said Joshua Britton, PhD, Founder and CEO of Debut.

The predictive capabilities of Debut’s proprietary, in-house skin health datasets recently surpassed publicly available datasets, achieving 99 percent data consistency compared to 85 percent in public datasets. “This means we can predict better ingredients, faster, with our best-in-class models that we have invested in over several years. We are excited to go after novel chemical entities (NCEs), as opposed to chasing existing ingredients in nature, to pioneer skin health innovation and support the growth of beauty brands,” said Britton.

Debut’s funding raise comes at a time marked by increased investor caution. The company is poised to enter the Asian market which is driven by advanced formulations and high-performance skincare. “AI combined with an understanding of skin biology enables the creation of custom formulation solutions for different geographies that has previously not been possible,” said Britton. Debut’s expansion into Asia will begin in Singapore where the company will be partnering with leading brands to create custom ingredients and formulations for longevity skincare.

The most recent fundraising round was supported by Fine Structure Ventures, EDBI, Wealthberry, BOLD (the venture fund of L’Oréal), GS Futures, Sandbox Industries and Material Impact, among others.

Debut

The leader in biotech beauty

Debut is building the future of beauty with cutting-edge AI and biotechnology, creating high-performing, innovative ingredients and formulations that propel the industry forward. The company specializes in scientifically-discovered, clinically-proven and inherently sustainable ingredients that provide maximum efficacy. Named one of the TIME100 Most Innovative Companies 2025, Debut is redefining the beauty industry’s standards, centering on performance, potency and purity. 

SOURCE Debut Biotechnology